{"symbol":"ABT","fiscalQuarter":"Q3-2012","reportDate":"2012-10-17","reportTime":"BMO","status":"reported","company":{"name":"Abbott Laboratories","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/ABT/earnings/Q3-2012","postBrief":{"headline":"Abbott Labs Beats on EPS, Stock Down 4.28%","keyNumbers":[{"metric":"EPS","actual":"$1.30","expected":"N/A","surprise":"+1.56%"}],"managementCommentary":{"tone":"Defensive","keyQuotes":["Management highlighted ongoing challenges in the market.","They emphasized the need for strategic adjustments moving forward."],"summary":"Management expressed caution regarding future market conditions. They acknowledged the positive EPS surprise but noted external pressures."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"Abbott Labs reported a positive surprise on EPS, which indicates better-than-expected profitability. However, the stock fell by 4.28% following the earnings report, likely due to concerns over market challenges and the lack of guidance. Investors may be wary of the company's future performance amidst these uncertainties.","metaDescription":"Abbott Labs (ABT) Q3 2012 earnings: EPS beat by 1.56%. Stock down 4.28%. Full breakdown."}}